Literature DB >> 28024092

Agreement and Predictive Validity Using Less-Conservative Foundation for the National Institutes of Health Sarcopenia Project Weakness Cutpoints.

Nancy Chiles Shaffer1, Luigi Ferrucci1, Michelle Shardell1, Eleanor M Simonsick1, Stephanie Studenski1.   

Abstract

OBJECTIVES: To derive lean mass cutpoints based on a less-conservative Foundation for the National Institutes of Health (FNIH) Sarcopenia Project Weakness cutpoint for grip strength (WeakI ) and to assess their agreement with European Working Group on Sarcopenia in Older People (EWGSOP) and prediction of incident slow walking and mortality.
DESIGN: Longitudinal analysis.
SETTING: Baltimore Longitudinal Study of Aging. PARTICIPANTS: Individuals aged 65 and older (287 men, 258 women) with 2 to 10 years of follow-up. MEASUREMENTS: Weakness was determined according to handgrip strength using a hand dynamometer, appendicular lean mass (ALM) using dual-energy X-ray absorptiometry, and walking speed according to 6-m usual pace walk speed. Analyses were performed using classification and regression tree analysis, Cohen's kappa, and Cox models.
RESULTS: Cutpoints derived from WeakI for ALM (ALMI ) were less than 21.4 kg in men and less than 14.1 kg in women and for ALM adjusted for body mass index (ALM/BMII ) were less than 0.725 in men and less than 0.591 in women. Kappas with EWGSOP were 0.65 for men and 0.75 for women for ALMI and 0.34 for men and 0.47 for women for ALM/BMII . Men with WeakI + ALMI were twice as likely to develop slow walking as those not weak with normal ALMI (Hazard ratio (HR) = 2.44, 95% confidence interval (CI) = 1.02-5.82). Under EWGSOP, men with weakness and low RALM were almost 3 times as likely to develop slow walking as those not weak with normal RALM (HR = 2.91, 95% CI = 1.11-7.62). Neither approach predicted incident slow walking in women.
CONCLUSION: The ALMI cutpoints agree with EWGSOP and predict slow walking in men. Future studies should explore sex differences in the relationship between body composition and physical function and the effect of change in muscle mass on muscle strength and physical function.
© 2016, Copyright the Authors Journal compilation © 2016, The American Geriatrics Society.

Entities:  

Keywords:  aging; muscle; sarcopenia; weakness

Mesh:

Year:  2016        PMID: 28024092      PMCID: PMC5357162          DOI: 10.1111/jgs.14706

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  12 in total

1.  Epidemiology of sarcopenia among the elderly in New Mexico.

Authors:  R N Baumgartner; K M Koehler; D Gallagher; L Romero; S B Heymsfield; R R Ross; P J Garry; R D Lindeman
Journal:  Am J Epidemiol       Date:  1998-04-15       Impact factor: 4.897

2.  Comparative performance of current definitions of sarcopenia against the prospective incidence of falls among community-dwelling seniors age 65 and older.

Authors:  H A Bischoff-Ferrari; J E Orav; J A Kanis; R Rizzoli; M Schlögl; H B Staehelin; W C Willett; B Dawson-Hughes
Journal:  Osteoporos Int       Date:  2015-06-12       Impact factor: 4.507

3.  Activities and attitudes of participants in the Baltimore longitudinal study.

Authors:  J L Stone; A H Norris
Journal:  J Gerontol       Date:  1966-10

4.  Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People.

Authors:  Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni
Journal:  Age Ageing       Date:  2010-04-13       Impact factor: 10.668

5.  Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort.

Authors:  A Y Bijlsma; C G M Meskers; C H Y Ling; M Narici; S E Kurrle; I D Cameron; R G J Westendorp; A B Maier
Journal:  Age (Dordr)       Date:  2013-06

6.  "Skeletal muscle function deficit" in a nationally representative British birth cohort in early old age.

Authors:  Rachel Cooper; David Bann; Elizabeth G Wloch; Judith E Adams; Diana Kuh
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-11-27       Impact factor: 6.053

7.  An evidence-based comparison of operational criteria for the presence of sarcopenia.

Authors:  Thuy-Tien Dam; Katherine W Peters; Maren Fragala; Peggy M Cawthon; Tamara B Harris; Robert McLean; Michelle Shardell; Dawn E Alley; Anne Kenny; Luigi Ferrucci; Jack Guralnik; Douglas P Kiel; Steve Kritchevsky; Maria T Vassileva; Stephanie Studenski
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05       Impact factor: 6.053

8.  Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project.

Authors:  Robert R McLean; Michelle D Shardell; Dawn E Alley; Peggy M Cawthon; Maren S Fragala; Tamara B Harris; Anne M Kenny; Katherine W Peters; Luigi Ferrucci; Jack M Guralnik; Stephen B Kritchevsky; Douglas P Kiel; Maria T Vassileva; Qian-Li Xue; Subashan Perera; Stephanie A Studenski; Thuy-Tien L Dam
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05       Impact factor: 6.053

9.  The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates.

Authors:  Stephanie A Studenski; Katherine W Peters; Dawn E Alley; Peggy M Cawthon; Robert R McLean; Tamara B Harris; Luigi Ferrucci; Jack M Guralnik; Maren S Fragala; Anne M Kenny; Douglas P Kiel; Stephen B Kritchevsky; Michelle D Shardell; Thuy-Tien L Dam; Maria T Vassileva
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05       Impact factor: 6.053

10.  Grip strength cutpoints for the identification of clinically relevant weakness.

Authors:  Dawn E Alley; Michelle D Shardell; Katherine W Peters; Robert R McLean; Thuy-Tien L Dam; Anne M Kenny; Maren S Fragala; Tamara B Harris; Douglas P Kiel; Jack M Guralnik; Luigi Ferrucci; Stephen B Kritchevsky; Stephanie A Studenski; Maria T Vassileva; Peggy M Cawthon
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2014-05       Impact factor: 6.053

View more
  8 in total

1.  Use of Raman spectroscopy to screen diabetes mellitus with machine learning tools.

Authors:  Edgar Guevara; Juan Carlos Torres-Galván; Miguel G Ramírez-Elías; Claudia Luevano-Contreras; Francisco Javier González
Journal:  Biomed Opt Express       Date:  2018-09-26       Impact factor: 3.732

2.  Identifying Sarcopenia in Female Long-Term Care Residents: A Comparison of Current Guidelines.

Authors:  Mary P Kotlarczyk; Subashan Perera; David A Nace; Neil M Resnick; Susan L Greenspan
Journal:  J Am Geriatr Soc       Date:  2017-11-20       Impact factor: 5.562

3.  The incidence of sarcopenia among hospitalized older patients: results from the Glisten study.

Authors:  Anna Maria Martone; Lara Bianchi; Pasquale Abete; Giuseppe Bellelli; Mario Bo; Antonio Cherubini; Francesco Corica; Mauro Di Bari; Marcello Maggio; Giovanna Maria Manca; Emanuele Marzetti; Maria Rosaria Rizzo; Andrea Rossi; Stefano Volpato; Francesco Landi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2017-09-14       Impact factor: 12.910

4.  GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community.

Authors:  T Cederholm; G L Jensen; M I T D Correia; M C Gonzalez; R Fukushima; T Higashiguchi; G Baptista; R Barazzoni; R Blaauw; A J S Coats; A N Crivelli; D C Evans; L Gramlich; V Fuchs-Tarlovsky; H Keller; L Llido; A Malone; K M Mogensen; J E Morley; M Muscaritoli; I Nyulasi; M Pirlich; V Pisprasert; M A E de van der Schueren; S Siltharm; P Singer; K Tappenden; N Velasco; D Waitzberg; P Yamwong; J Yu; A Van Gossum; C Compher
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-02       Impact factor: 12.910

5.  Vertical Jump Tests: A Safe Instrument to Improve the Accuracy of the Functional Capacity Assessment in Robust Older Women.

Authors:  Carlos A F Santos; Gislene R Amirato; Alessandro F Jacinto; Ana V Pedrosa; Adriana Caldo-Silva; António R Sampaio; Nuno Pimenta; Juliana M B Santos; Alberto Pochini; André L L Bachi
Journal:  Healthcare (Basel)       Date:  2022-02-08

6.  Incident Impaired Cognitive Function in Sarcopenic Obesity: Data From the National Health and Aging Trends Survey.

Authors:  John A Batsis; Christian Haudenschild; Robert M Roth; Tyler L Gooding; Meredith N Roderka; Travis Masterson; John Brand; Matthew C Lohman; Todd A Mackenzie
Journal:  J Am Med Dir Assoc       Date:  2020-10-21       Impact factor: 4.669

Review 7.  Reference Values for Skeletal Muscle Mass - Current Concepts and Methodological Considerations.

Authors:  Carina O Walowski; Wiebke Braun; Michael J Maisch; Björn Jensen; Sven Peine; Kristina Norman; Manfred J Müller; Anja Bosy-Westphal
Journal:  Nutrients       Date:  2020-03-12       Impact factor: 5.717

8.  Diurnal Salivary Cortisol in Sarcopenic Postmenopausal Women: The OsteoLaus Cohort.

Authors:  Elena Gonzalez Rodriguez; Pedro Marques-Vidal; Bérengère Aubry-Rozier; Georgios Papadakis; Martin Preisig; Christine Kuehner; Peter Vollenweider; Gerard Waeber; Didier Hans; Olivier Lamy
Journal:  Calcif Tissue Int       Date:  2021-05-18       Impact factor: 4.333

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.